Normal motility of the colon is critical for quality of life and efforts to normalize abnormal colon function have had limited success. A better understanding of control systems of colonic motility is therefore essential. We report here a hypothesis with supporting experimental data to explain the origin of rhythmic propulsive colonic motor activity induced by general distention. The theory holds that both networks of interstitial cells of Cajal (ICC), those associated with the submuscular plexus (ICC–SMP) and those associated with the myenteric plexus (ICC–MP), orchestrate propagating contractions as pacemaker cells in concert with the enteric nervous system (ENS). ICC–SMP generate an omnipresent slow wave activity that causes propagating but non-propulsive contractions (“rhythmic propagating ripples”) enhancing absorption. The ICC–MP generate stimulus-dependent cyclic depolarizations propagating anally and directing propulsive activity (“rhythmic propulsive motor complexes”). The ENS is not essential for both rhythmic motor patterns since distention and pharmacological means can produce the motor patterns after blocking neural activity, but it supplies the primary stimulus in vivo. Supporting data come from studies on segments of the rat colon, simultaneously measuring motility through spatiotemporal mapping of video recordings, intraluminal pressure, and outflow measurements.
The aim of the present work is to investigate a putative junction transmission [nitric oxide (NO) and ATP] in the human colon and to characterize the electrophysiological and mechanical responses that might explain different functions from both neurotransmitters. Muscle bath and microelectrode techniques were performed on human colonic circular muscle strips. The NO donor sodium nitroprusside (10 M), but not the P2Y receptor agonist adenosine 5Ј-O-2-thiodiphosphate (10 M), was able to cause a sustained relaxation. N G -nitro-L-arginine (L-NNA) (1 mM), a NO synthase inhibitor, but not 2Ј-deoxy-N 6 -methyl adenosine 3Ј,5Ј-diphosphate tetraammonium salt (MRS 2179) (10 M), a P2Y antagonist, increased spontaneous motility. Electrical field stimulation (EFS) at 1 Hz caused fast inhibitory junction potentials (fIJPs) and a relaxation sensitive to MRS 2179 (10 M). EFS at higher frequencies (5 Hz) showed biphasic IJP with fast hyperpolarization sensitive to MRS 2179 followed by sustained hyperpolarization sensitive to L-NNA; both drugs were needed to fully block the EFS relaxation at 2 and 5 Hz. Two consecutive single pulses induced MRS 2179-sensitive fIJPs that showed a rundown. The rundown mechanism was not dependent on the degree of hyperpolarization and was present after incubation with L-NNA (1 mM), hexamethonium (100 M), MRS 2179 (1 M), and NF023 (10 M). We concluded that single pulses elicit ATP release from enteric motor neurons that cause a fIJP and a transient relaxation that is difficult to maintain over time; also, NO is released at higher frequencies causing a sustained hyperpolarization and relaxation. These differences might be responsible for complementary mechanisms of relaxation being phasic (ATP) and tonic (NO).ATP; IJP; smooth muscle; rundown; purinergic receptors THE IDENTITY OF THE INHIBITORY neurotransmitter(s) involved in nonadrenergic, noncholinergic (NANC) inhibitory neurotransmission is still being debated, but ATP and nitric oxide (NO) are presently recognized as two of the major inhibitory mediators in the gastrointestinal (GI) tract. Nitrergic neurons mediate lower esophageal sphincter relaxation after swallowing (34), and vagally induced gastric (11) and pyloric (2) relaxation regulate colonic transit time (26) and mediate the rectoanal inhibitory reflex (28). Fewer studies have been published on the putative role of ATP as a neurotransmitter mediating these physiological functions. ATP and NO might participate in the regulation of gastroduodenal motility in rats, (17) and ATP might participate in vagally induced gastric relaxation (4) and intrinsic gastric adaptive relaxation in mice (12). These (and other) data suggest that these neurotransmitters have important physiological functions; however, smooth muscle relaxation might have different properties (i.e., tonic vs. phasic) that should be better characterized. The release of inhibitory neurotransmitter(s) at the neuromuscular junction is the final step for smooth muscle relaxation. Inhibitory junction potentials (IJPs) have been well c...
Key points• Neural-mediated relaxation occurs in the gastrointestinal tract. To accomplish this function, two neurotransmitters, ATP or a related purine and nitric oxide, are released by inhibitory motorneurons.• The type of purinergic receptor is still under debate but previous data using a classical pharmacological approach (receptor agonists and antagonists) suggested that P2Y 1 receptors are responsible for purinergic neurotransmission in the gastrointestinal tract.• In the present study we used a genetically modified mouse in which P2Y 1 receptors had been knocked out.• P2Y 1 -deficient mice had functional nitrergic neurotransmission but purinergic neurotransmission was absent.• The present work confirms the hypothesis demonstrating that P2Y 1 receptors mediate the purinergic component of the smooth muscle relaxation in the gastrointestinal tract.Abstract Purinergic and nitrergic co-transmission is the dominant mechanism responsible for neural-mediated smooth muscle relaxation in the gastrointestinal tract. The aim of the present paper was to test whether or not P2Y 1 receptors are involved in purinergic neurotransmission using P2Y 1 −/− knock-out mice. Tension and microelectrode recordings were performed on colonic strips. In wild type (WT) animals, electrical field stimulation (EFS) caused an inhibitory junction potential (IJP) that consisted of a fast IJP (MRS2500 sensitive, 1 μM) followed by a sustained IJP (N ω -nitro-L-arginine (L-NNA) sensitive, 1 mM). The fast component of the IJP was absent in P2Y 1 −/− mice whereas the sustained IJP (L-NNA sensitive) was recorded. In WT animals, EFS-induced inhibition of spontaneous motility was blocked by the consecutive addition of L-NNA and MRS2500. In P2Y 1 −/− mice, EFS responses were completely blocked by L-NNA. In WT and P2Y 1 −/− animals, L-NNA induced a smooth muscle depolarization but 'spontaneous' IJP (MRS2500 sensitive) could be recorded in WT but not in P2Y 1 −/− animals. Finally, in WT animals, 1 μM MRS2365 caused a smooth muscle hyperpolarization that was blocked by 1 μM MRS2500. In contrast, 1 μM MRS2365 did not modify smooth muscle resting membrane potential in P2Y 1 −/− mice. β-Nicotinamide adenine dinucleotide (β-NAD, 1 mM) partially mimicked the effect of MRS2365. We conclude that P2Y 1 receptors mediate purinergic neurotransmission in the gastrointestinal tract and β-NAD partially fulfils the criteria to participate in rodent purinergic neurotransmission. The P2Y 1 −/− mouse is a useful animal model to study the selective loss of purinergic neurotransmission.
BACKGROUND AND PURPOSEThe role of hydrogen sulphide (H2S) as a putative endogenous signalling molecule in the gastrointestinal tract has not yet been established. We investigated the effect of D,L-propargylglycine (PAG), an inhibitor of cystathionine g-lyase (CSE), amino-oxyacetic acid (AOAA) and hydroxylamine (HA), inhibitors of cystathionine b-synthase (CBS) on rat colonic motility. EXPERIMENTAL APPROACHImmunohistochemistry, H2S production, microelectrode and organ bath recordings were performed on rat colonic samples without mucosa and submucosa to investigate the role of endogenous H2S in motility. KEY RESULTSCSE and CBS were immunolocalized in the colon. H2S was endogenously produced (15.6 Ϯ 0.7 nmol·min -1 ·g -1 tissue) and its production was strongly inhibited by PAG (2 mM) and AOAA (2 mM). PAG (2 mM) caused smooth muscle depolarization and increased spontaneous motility. The effect was still recorded after incubation with tetrodotoxin (TTX, 1 mM) or N w -nitro-Larginine (L-NNA, 1 mM). AOAA (2 mM) caused a transient (10 min) increase in motility. In contrast, HA (10 mM) caused a 'nitric oxide-like effect', smooth muscle hyperpolarization and relaxation, which were antagonized by 1H- [1,2,4] oxadiazolo [4,3-a]quinoxalin-1-one (ODQ, 10 mM). Neither spontaneous nor induced inhibitory junction potentials were modified by AOAA or PAG. CONCLUSIONS AND IMPLICATIONSWe demonstrated that H2S is endogenously produced in the rat colon. PAG and AOAA effectively blocked H2S production. Our data suggest that enzymatic production of H2S regulates colonic motility and therefore H2S might be a third gaseous inhibitory signalling molecule in the gastrointestinal tract. However, possible non-specific effects of the inhibitors should be considered. AbbreviationsAOAA, amino-oxyacetic acid; AUC, area under the curve; CBS, cystathionine b-synthase; CSE, cystathionine g-lyase; D-AP5, D-(-)-2-amino-5-phosphonopentanoic acid; EFS, electrical field
Background and purpose: Inhibitory junction potentials (IJP) are responsible for smooth muscle relaxation in the gastrointestinal tract. The aim of this study was to pharmacologically characterize the neurotransmitters [nitric oxide (NO) and adenosine triphosphate (ATP)] and receptors involved at the inhibitory neuromuscular junctions in the rat colon using newly available P2Y1 antagonists. Experimental approach: Organ bath and microelectrode recordings were used to evaluate the effect of drugs on spontaneous mechanical activity and resting membrane potential. IJP and mechanical relaxation were studied using electrical field stimulation (EFS). Key results: N w -nitro-L-arginine (L-NNA) inhibited the slow component of the IJP and partially inhibited the mechanical relaxation induced by EFS. MRS2179, MRS2500 and MRS2279, all selective P2Y1 receptor antagonists, inhibited the fast component of the IJP without having a major effect on the relaxation induced by EFS. The combination of both L-NNA and P2Y1 antagonists inhibited the fast and the slow components of the IJP and completely blocked the mechanical relaxation induced by EFS. Sodium nitroprusside caused smooth muscle hyperpolarization and cessation of spontaneous motility that was prevented by oxadiazolo[4,3-a]quinoxalin-1-one. Adenosine 5′-O-2-thiodiphosphate, a preferential P2Y agonist, hyperpolarized smooth muscle cells and decreased spontaneous motility. This effect was inhibited by P2Y1 antagonists. Conclusions and implications:The co-transmission process in the rat colon involves ATP and NO. P2Y1 receptors mediate the fast IJP and NO the slow IJP. The rank order of potency of the P2Y1 receptor antagonists is MRS2500 greater than MRS2279 greater than MRS2179. P2Y1 receptors might be potential pharmacological targets for the regulation of gastrointestinal motility.
Nitric oxide (NO) and ATP mediate smooth muscle relaxation in the gastrointestinal tract. However, the involvement of these neurotransmitters in spontaneous neuronal activity is unknown. The aim of the present work was to study spontaneous neuromuscular transmission in the rat midcolon. Microelectrode experiments were performed under constant stretch both in circular and longitudinal directions. Spontaneous inhibitory junction potentials (sIJP) were recorded. Tetrodotoxin (1 microM) and apamin (1 microM) depolarized smooth muscle cells and inhibited sIJP. N(omega)-nitro-l-arginine (l-NNA, 1 mM) depolarized smooth muscle cells but did not modify sIJP. In contrast, the P2Y(1) antagonist MRS-2500 (1 microM) did not modify the resting membrane potential (RMP) but reduced sIJP (IC(50) = 3.1 nM). Hexamethonium (200 microM), NF-023 (10 microM), and ondansetron (1 microM) did not modify RMP and sIJP. These results correlate with in vitro (muscle bath) and in vivo (strain gauges) data where l-NNA but not MRS-2500 induced a sustained increase of spontaneous motility. We concluded that, in the rat colon, inhibitory neurons regulate smooth muscle RMP and cause sIJP. In vitro, the release of inhibitory neurotransmitters is independent of nicotinic, P2X, and 5-hydroxytryptamine type 3 receptors. Neuronal NO causes a sustained smooth muscle hyperpolarization that is responsible for a constant inhibition of spontaneous motility. In contrast, ATP acting on P2Y(1) receptors is responsible for sIJP but does not mediate inhibitory neural tone. ATP and NO have complementary physiological functions in the regulation of gastrointestinal motility.
Inhibitory purinergic neuromuscular transmission in the human colon was pharmacologically assessed by the use of new P2Y(1) receptor antagonists MRS2179, MRS2279, and MRS2500. The rank order of potency of the P2Y(1) antagonists is MRS2500 > MRS2279 > MRS2179. We found that β-NAD partially fulfills the criteria to be considered an inhibitory neurotransmitter in the human colon, but the relative contribution of each purine (ATP/ADP vsβ-NAD) requires further studies.
(ICC), and fibroblast-like cells. Up to date, the interplay between neurons and these cells to initiate a nitrergic inhibitory junction potential (IJP) is unclear. Here, we investigate the origin of the nitrergic IJP in murine fundus and colon. IJPs were determined in fundus and colon SMC of mice lacking NO-GC globally (GCKO) and specifically in SMC (SM-GCKO), ICC (ICC-GCKO), and both SMC/ICC (SM/ICC-GCKO). Nitrergic IJP was abolished in ICC-GCKO fundus and reduced in SM-GCKO fundus. In the colon, the amplitude of nitrergic IJP was reduced in ICC-GCKO, whereas nitrergic IJP in SM-GCKO was reduced in duration. These results were corroborated by loss of the nitrergic IJP in global GCKO. In conclusion, our results prove the obligatory role of NO-GC in ICC for the initiation of an IJP. NO-GC in SMC appears to enhance the nitrergic IJP, resulting in a stronger and prolonged hyperpolarization in fundus and colon SMC, respectively. Thus NO-GC in both cell types is mandatory to induce a full nitrergic IJP. Our data from the colon clearly reveal the nitrergic IJP to be biphasic, resulting from individual inputs of ICC and SMC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.